Skip to content
Post Test and Evaluation
Please note that to receive credit you must achieve a score of at least 70%.
Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.
Post-Activity Test
1.
Which of the following statements regarding OAB is least accurate?
(Required.)
OAB is similarly prevalent in men and women.
Incontinence associated with OAB is more prevalent in women than men.
OAB mainly impacts older adults (>60 years of age).
Less than 50% of those with OAB will discuss their condition with a healthcare provider.
2.
The most appropriate initial diagnostic test for a patient with OAB symptoms is:
(Required.)
Urodynamics
Urinalysis with urine culture
Post-void residual
Cystoscopy
3.
Stress incontinence must be present for an OAB diagnosis.
(Required.)
True
False
4.
All of the following lifestyle changes can improve OAB symptoms except:
(Required.)
Quit smoking
Reduce weight
Limit caffeine intake
Take a daily vitamin D supplement
5.
According to the AUA, first-line treatment of OAB is:
(Required.)
Behavioral therapy
Anti-muscarinic therapy
Beta3-agonist therapy
Botulinum toxin injection
6.
Behavioral therapy includes all of the following except:
(Required.)
Bladder training
Pelvic floor muscle training
Scheduled voiding
Home catheterization
7.
According to AUA, second-line treatment of OAB can include any of the following except:
(Required.)
Immediate-release antimuscarinic therapy
Extended-release antimuscarinic therapy
Beta3-agonist
Botulinum toxin injection
8.
Which of the following adverse effects is most common with antimuscarinic agent use?
(Required.)
Headache
Urinary tract infection
Dry mouth
Hypertension
9.
All of the following are appropriate options for a patient complaining of dry mouth while taking an antimuscarinic agent except:
(Required.)
Switch to another antimuscarinic agent
Increase the dose
Switch to a beta3-agonist
Encourage the use of sugar-free gum
10.
For a patient with refractory OAB who has failed behavioral therapy and treatment with an antimuscarinic agent, appropriate options include all of the following except:
(Required.)
Switch to a beta3-agonist or another antimuscarinic agent
Consider combination therapy
Discontinue treatment as the patient is likely nonadherent
Referral to a urologist
